July 28, 2015

Time for Congress to Fix Discriminatory Chemotherapy Payment Policy for Patients

In her most recent Morning Consult column, titled, “Time for Congress to Fix Discriminatory Chemotherapy Payment Policy for Patients,” District Policy President Ilisa Halpern Paul discusses how Congress has the opportunity to make self-administered cancer drugs more affordable. 

Historically, cancer drugs that were prescribed to patients were administered in a physician’s office or outpatient client. While self-administered drugs are becoming increasingly popular, they can be extremely expensive. Multiple members of Congress have joined together in a bipartisan alliance to introduce Cancer Drug Coverage Parity Act of 2015, which, if enacted, would require out-of-pocket payment parity for all types of anticancer drugs, irrespective of the formulation.

Click here to read “Time for Congress to Fix Discriminatory Chemotherapy Payment Policy for Patients.”

Services and Industries

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.